v3.26.1
Revenues from Contracts with Customers
9 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenues from Contracts with Customers REVENUES FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue from Contracts with Customers—The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance:
Three Months Ended
March 31,
Nine Months Ended
March 31,
(in thousands)
2026202520262025
Senior:
Medicare advantage commissions$174,132 $145,453 $447,040 $446,640 
Other Senior commissions
3,282 3,345 12,220 8,111 
Other services5,476 20,644 44,166 63,179 
Total Senior revenue182,890 169,442 503,426 517,930 
Healthcare Services:
Pharmacy195,270 185,271 641,023 518,154 
Other services4,116 4,298 10,368 10,523 
Total Healthcare Services revenue199,386 189,569 651,391 528,677 
Life:
Term commissions20,605 20,139 58,372 55,169 
Final expense commissions21,860 20,188 64,194 54,795 
Other services5,431 5,515 15,600 15,029 
Total Life revenue47,896 45,842 138,166 124,993 
All other:
Commissions2,818 4,900 9,085 14,667 
Other services266 377 1,537 717 
Total All other revenue
3,084 5,277 10,622 15,384 
Eliminations:
Commissions(994)(867)(2,807)(2,531)
Other services(1,329)(1,103)(3,952)(2,961)
Total Elimination revenue(2,323)(1,970)(6,759)(5,492)
Total Commissions and other services revenue235,663 222,889 655,823 663,338 
Total Pharmacy revenue195,270 185,271 641,023 518,154 
Total Revenue$430,933 $408,160 $1,296,846 $1,181,492 

Contract Balances—The Company has contract assets related to commissions receivable from its insurance carrier partners, with the movement over time as the policy is renewed between long-term and short-term commissions receivable and accounts receivable, net being the main activity, along with commission revenue adjustments from changes in estimates.
A roll forward of commissions receivable (current and long-term) is shown below for the period presented:
(in thousands)
Balance as of June 30, 2025
$950,828 
Commission revenue from revenue recognized244,027 
Net commission revenue adjustment from change in estimate14,277 
Amounts recognized as accounts receivable, net(249,603)
Balance as of March 31, 2026
$959,529 

For the nine months ended March 31, 2026, the $14.3 million net commission revenue adjustment from change in estimate includes adjustments related to revenue recognized in prior fiscal years, based on the Company’s reassessment of each of its cohorts’ transaction prices. It includes a positive adjustment of $15.0 million for Senior and a negative adjustment of $0.3 million for Life. The remaining negative adjustment of $0.4 million relates to the Company’s All other non-reportable segment. Refer to Note 15 to the condensed consolidated financial statements for further details on the Company’s reportable segments.

The Company’s contract liabilities are included within other current liabilities on the condensed consolidated balance sheets and represent unamortized upfront payments received for commission revenue for which the performance obligations have not yet been met and are anticipated to be recognized over the next twelve months.

A roll forward of contract liabilities (current) is shown below for the period presented:
(in thousands)
Balance as of June 30, 2025
$698 
Commission and other services revenue recognized(14,057)
Amounts recognized as contract liabilities13,640 
Balance as of March 31, 2026
$281